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AdaSGC binds Hsc70s to inhibit ATPase activity.
Using single-turnover assays, adaSGC, a soluble
SGC mimic, preferentially inhibited Hsp40-activated
Hsc70 ATP hydrolysis (Ki  10 mM) to reduce
C-terminal Hsc70-peptide binding and, potentially,
chaperone function. ERAD of misfolded DF508
CFTR requires Hsc70-Hsp40 chaperones. In trans-
fected baby hamster kidney (BHK) cells, adaSGC
increased DF508CFTR ERAD escape, and after
low-temperature glycerol rescue, maturation, and
iodide efflux. Inhibition of SGC biosynthesis reduced
DF508CFTR but not wtCFTR expression, whereas
depletion of other glycosphingolipids had no affect.
WtCFTR transfected BHK cells showed increased
SGC synthesis compared with DF508CFTR/mock-
transfected cells. Partial rescue of DF508CFTR by
low-temperature glycerol increased SGC synthesis.
AdaSGC also increased cellular endogenous SGC
levels. SGC in the lung, liver, and kidneywas severely
depleted in DF508CFTR compared with wtCFTR
mice, suggesting a role for CFTR in SGC biosyn-
thesis.
INTRODUCTION
The cystic fibrosis transmembrane regulator (CFTR) is a multi-
spanning membrane ATP-regulated chloride channel (Riordan
et al., 1989). Defects in the activity and cell surface trafficking
of CFTR result in the loss of chloride transport and the develop-
ment of cystic fibrosis (CF). Although many mutations in CFTR
have been described in CF patients, the DF508CFTR mutation
is of particular interest because this is the most common CF
mutation and the protein retains chloride transport activity
(Denning et al., 1992). Cell surface trafficking and stability are
impaired due to misfolding and subsequent degradation by the
cellular quality control machinery. It is speculated that interven-
tive procedures that allow the cell surface trafficking of
DF508CFTR will be sufficient to ameliorate the CF phenotype
(Farmen et al., 2005; Amaral, 2005). Hsp70-related chaperonesChemistry & Biology 16are an important component of the endoplasmic reticulum asso-
ciated degradation (ERAD) quality control mechanism respon-
sible for the elimination of misfolded proteins such as
DF508CFTR (Brodsky, 2001). In addition, a significant fraction
of wild-type (wt) CFTR is degraded by the ERAD pathway
(Lukacs et al., 1994). Hsp70 chaperone function is primarily
involved in nascent polypeptide folding, whereas the constitutive
homolog, Hsc70, appears to play amore significant role in ERAD
(Hohfeld et al., 2001). It has been shown that wtCFTR and
DF508CFTR are degraded by the ubiquitin-proteasome pathway
(Ward et al., 1995). Other studies have implicated members of
the Hsp70 family in the cell surface turnover of CFTR (and other
proteins) via the ubiquitination pathway (Zhang et al., 2001).
Members of the Hsp70 family are also prominently induced
following DF508CFTR expression (Singh et al., 2006; Xu et al.,
2006).
Our laboratory has been interested in the cell surface receptor
function of sulfogalactosyl ceramide (SGC) and has shown that
members of the Hsp70 chaperone family specifically bind this
glycosphingolipid (GSL) (Mamelak et al., 2001a) within the
N-terminal ATPase domain (Mamelak and Lingwood, 2001),
such that cell surface Hsp70s primarily expressed on bacterial
pathogens can mediate binding to host cell SGC (Lingwood
et al., 1990; Huesca et al., 1996; Hartmann et al., 2001). Adaman-
tylSGC (adaSGC) was developed as a water-soluble mimic of
membrane SGC (Mamelak et al., 2001b), which retained
receptor function. The fatty acid of SGC is replaced with an ada-
mantane frame. This results in little change in hydrophobicity but
a large increase in water partitioning (Whetstone and Lingwood,
2003).
AdaSGC (or SGC) binding to the Hsc70 ATPase domain was
shown to inhibit Hsc70 ATPase activity (Whetstone and Ling-
wood, 2003). AdaSGC retains membrane permeability and was
considered, therefore, as a potential inhibitor of cellular Hsc70-
mediated chaperone function. Hsc70 inhibition has been found
to augment DF508 ERAD escape and cell surface expression
(Rubenstein et al., 1997; Rubenstein and Zeitlin, 2000).
AdaSGC might, therefore, modulate DF508CFTR expression
by inhibiting the chaperone function of Hsp70 family members.
We also investigated endogenous SGC expression in wtCFTR
and DF508CFTR mutant cells and mice. Our results indicate
that AdaSGC increased DF508CFTR degradation escape to
augment low-temperature/glycerol maturation of DF508CFTR., 461–470, April 24, 2009 ª2009 Elsevier Ltd All rights reserved 461
Chemistry & Biology
AdamantylSGC Augments DF508CFTR RescueSGC expression is increased in cells and mice expressing
wtCFTR.
Figure 1. AdamantylSGC Inhibition of Yeast
Hsc70 ATPase Activity-Single Turnover
Assay
(A) Yeast Hsc70 (Ssa1p) was preloaded with [32P]
ATP ± SV40 T antigen (TAg, J-domain-containing
protein) on ice and 32P release from the purified
complex ± adaSGC (300 mM added at 50 s) moni-
tored with incubation at 30C. Means of triplicate
determinations ± standard error are shown. B
Yeast Hsc70 (Ssa1p); d Yeast Hsc70 (Ssa1p) +
300 mM adaSGC;, Yeast Hsc70 (Ssa1p) + TAg;
- Yeast Hsc70 (Ssap1) + TAg + 300 mM adaSGC.
(B) Inhibition of T antigen stimulated Hsc70 single-
turnover ATPase activity was monitored as a func-
tion of adaSGC concentration.
(C) Structure of adamantylSGC (adaSGC).
whether adaSGC could inhibit Hsc70-
peptide binding, 125I-carboxylmethylated
a-lactalbumin (CMLA), a permanently
unfolded Hsc70 chaperone substrate
(McClellan et al., 1998), and Hsc70 were
incubated in the presence or absence of
100 mM adaSGC (Figure 2). CMLA-Hsc70
complexes were detected (Figure 2, lanes
3 and 4), but the presence of 100 mM
adaSGC largely prevented the formation
of these CMLA-Hsc70 complexes, irre-
spective of the presence of Hsp40
(Figure 2, lanes 5 and 6). This result suggests that adaSGC inhibits
Hsc70-peptide complex formation or increases peptide dissocia-
tion in vitro.RESULTS
AdaSGC Inhibits Hsc70 ATPase Activity
The soluble analog of SGC, adaSGC (Figure 1C), inhibits bovine
Hsc70 ATPase activity in steady-state assays (Whetstone and
Lingwood, 2003). To specifically monitor the effects of adaSGC
on the ATP hydrolytic step, single-turnover assays were per-
formed using yeast Hsc70 (Ssa1p) in the presence or absence
of J domain containing SV40 T antigen (TAg). In this case, the
TAg was used as an Hsp40 mimic (i.e., a protein containing a
J domain), as previously described (Srinivasan et al., 1997;
Fewell et al., 2004). As expected, TAg stimulated Hsc70
ATPase activity. When 300 mM adaSGC was added in the pres-
ence of TAg, ATPase activity was reduced 2–4-fold. We found
that the inhibition of ATPase activity for the ATP preloaded chap-
erone in the presence of 300 mM adaSGC was dependent on
the presence of Hsp40 (Figure 1A). No inhibition of endogenous
Hsc70 ATPase activity in the absence of TAg was observed.
Within this single ATPase cycle, 70% of ADP formation was pre-
vented by adaSGC. The dose response for Hsp40-activated
Hsc70 ATPase inhibition (Figure 1B) showed a Ki of 10 mM for
adaSGC.
Inhibition of Hsc70 Peptide Binding by AdaSGC
Hsp70andHsc70chaperonesbindand releasepeptidesubstrates
concomitant with cycles of ATP binding/hydrolysis, and this
activity is essential for their function. Therefore, to investigate462 Chemistry & Biology 16, 461–470, April 24, 2009 ª2009 ElsevieEffect of AdamantylSGC on DF508CFTR Expression
DF508CFTR, the most common disease-causing CFTRmutation,
is subject to ERAD (Ward et al., 1995). A major step during the
ERAD of misfolded DF508CFTR might be the prolonged binding
to chaperone(s). This, in turn, might trigger subsequent proteinrFigure 2. AdamantylSGC Inhibits Hsc70-Peptide Binding
Yeast Hsc70 (Ssa1p) was incubated ± Hsp40 (Ydj1p), ± 100 mMadaSGC in the
presence of 125I-CMLA, a permanently unfolded, polypeptide substrate for
Hsp70s. The complex was separated by nondenaturing gel electrophoresis
and detected by autoradiography. AdaSGC prevented 125I-CMLA-Hsc70
complex formation both in the presence and absence of Hsp40.Ltd All rights reserved
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AdamantylSGC Augments DF508CFTR RescueFigure 3. AdamantylSGC Promotes DF508CFTR ERAD Escape
(A) WtCFTR and DF508CFTR-expressing BHK cells were cultured with 50 mM adaSGC for 48 hr. DF508CFTR BHK cells were rescued under low-temperature
(26C–27C) 10% glycerol. DF508CFTR expression was monitored by western blot (DF508). AdaSGC treatment enhances DF508CFTR expression under
rescuing condition (DF508R). One of four similar experiments is shown.
(B) Concentration dependent rescue effect of adaSGC. Up to 100 mM adaSGC treatment increased the fully glycosylated, mature form (band c) of DF508CFTR.
(C) Immunoprecipitation (IP) of rescued DF508CFTR BHK cells treated with 50 mm adaSGC. IP was performed with anti-HA and then an immunoblot was per-
formed using anti-CFTR. IP assay confirmed the increased DF508CFTR degradation escape by adaSGC treatment.
(D) Comparison of iodide efflux in rescued DF508CFTR BHK cells treated with or without 50 mM adaSGC. AdaSGC treatment markedly increases iodide efflux,
suggesting increased functional DF508CFTR in the plasma membrane. Mean of triplicate determinations ± standard error are shown.ubiquitination (Wardet al., 1995). Because adaSGC inhibitsHsc70
ATPase activity andHsc70-CMLAcomplex formation,wehypoth-
esized that DF508CFTR might be rescued from ERAD by
adaSGC. Treatment of wtCFTR cells with 50 mMadaSGC showed
no effect, but adaSGC treatment had a selective augmentaryChemistry & Biology 16effect on the levels of DF508CFTR. An increase in the immature
form (band b) of DF508CFTR was observed (Figure 3A), suggest-
ing increased escape from ERAD. Increased maturation, how-
ever, was not observed for DF508CFTR. Only when adaSGC-
treated cells were rescued by low-temperature (26C–27C), 461–470, April 24, 2009 ª2009 Elsevier Ltd All rights reserved 463
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AdamantylSGC Augments DF508CFTR RescueFigure 4. Functional CFTR Expression
Correlates with SGC Expression in BHK
Cell Transfectants and IB3/S9 Cells
(A) BHK cells transfected with HA-tagged wtCFTR
or DF508CFTR were tested for SGC content by
anti-SGC-TLC immunostaining of total lipid
extract. DF508CFTR cells were also tested after
low-temperature (26C–27C) 10% glycerol
rescue. SGC content was increased after wtCFTR
transfection and after rescue of DF508CFTR-
transfected cells (presumably due to DF508CFTR
maturation). IB3 cells (CF) contain lower levels of
SGC than S9 cells (wtCFTR corrected IB3). For
upper panel TLC, ECL was used for detection.
For lower panel TLC, 4-chloro-1-naphthol and
hydrogen peroxide were used to detect HRP-
conjugated goat anti-mouse IgG.
(B) Immunofluorescence staining of SGC expres-
sion in wtCFTR and DF508CFTR BHK cells. Cells
were fixed, permeabilized, and then stained with
anti-SGC. SGC expression, particularly around
the nucleus, is increased in wtCFTR-expressing
cells.10% glycerol treatment for 24 hr was a major increase in the level
of mature, lactosamine-glycosylated DF508CFTR observed.
Dose-dependent experiments showed that up to 100 mMadaSGC
could increase the level of fully glycosylated DF508CFTR under
rescuing conditions (Figure 3B), with maximum effect between
25 and 50 mM. The levels of both immature and mature
DF508CFTR were elevated as compared with nontreated cells.
Immunoprecipitation with antihemagglutinin followed by immuno-
blot with anti-CFTR also showed the increased expression of fully
glycosylated DF508CFTR (band c) by adaSGC (Figure 3C). No
effect on wtCFTR cells was evident.
AdamantylSGC Increases the Level of Iodide Efflux
in DF508CFTR-Transfected Cells
To confirm that rescued DF508CFTR is functional at the plasma
membrane, an iodide efflux assay was performed. Consistent
with the effect on DF508CFTR expression levels, adaSGC treat-
ment of DF508CFTR-transfected cells alone had no effect on
iodine efflux (data not shown). However, the treatment of
DF508CFTR-transfected cells with adaSGC under low-tempera-
ture glycerol treatment significantly stimulated iodide efflux, con-
firming the increased level of functional plasma membrane
DF508CFTR in these cells (Figure 3D).
Effect of CFTR Transfection on SGC Synthesis
Based on our findings that both SGC and adaSGC bind to Hsc70
and inhibit Hsc70 ATPase activity to reduce peptide binding, we
compared SGC expression in wtCFTR and DF508CFTR-
expressing cells. BHK cells stably transfected with the gene
encoding hemagglutinin (HA)-tagged wtCFTR or HA-tagged
DF508CFTR were used. The SGC content was assessed by
GSL extraction and thin-layer chromatography (TLC) immunos-
taining using monoclonal anti-SGC (Fredman et al., 1988).
SGC was barely detectable in mock-transfected cells but mark-
edly increased in wtCFTR-transfected cells (Figure 4A). This
increase was not observed for DF508CFTR-transfected cells
(Figure 4A). However, when such cells were ‘‘rescued’’ by low-
temperature glycerol conditions established to increase the464 Chemistry & Biology 16, 461–470, April 24, 2009 ª2009 Elseviermaturation and plasma membrane chloride transport by
DF508CFTR, SGC synthesis was elevated, similar to wtCFTR-
expressing cells (Figure 4A). The difference in SGC expression
between wtCFTR and DF508CFTR BHK cells was confirmed
by immunofluorescence staining using anti-SGC antibody
(Figure 4B). The staining of permeabilized cells showed exten-
sive perinuclear SGC, consistent with ER and thereby appropri-
ately located to affect ERAD.
GSL Modulation of CFTR Expression
The change of SGC expression in wild-type, DF508CFTR, and
rescued DF508CFTR suggests a possible relationship between
CFTR and SGC levels. To further examine this possibility, SGC
synthesis was modulated and the level of HA-tagged wtCFTR
and DF508CFTR in the transfected BHK cells was monitored
by western blot. Incubation of cells with the glucosyl ceramide
inhibitor P4 for 10 days had virtually no effect on wtCFTR or
DF508CFTR expression (Figure 5A). P4 depletes glucosyl
ceramide-based GSLs (95% of total GSLs). The synthesis of
SGC and its precursor, galactosyl ceramide, are unaffected
(Emam et al., 2006). Cell treatment with sodium chlorate,
a general sulfation inhibitor that depletes SGC, showed a selec-
tive inhibitory effect on DF508CFTR expression (Figure 5B). To
prevent total GSL synthesis, including SGC, ceramide synthase
was inhibited with fumonisin B1 (Soriano et al., 2005). Fumonisin
B1 treatment slightly increased the fully glycosylated form of
DF508CFTR, but, like sodium chlorate, decreased DF508CFTR
after rescue (Figure 5C). These GSL inhibitor experiments indi-
cate wtCFTR is unaffected by GSL depletion and that only
changes in SGC levels affect DF508CFTR expression, particu-
larly during rescue. Thus, decreased level of SGC could be one
of the consequences of, and contribute to, the cellular
phenomena associated with CF.
The effect of adaSGC on BHK cell SGC metabolism was
assessed. Treatment of cells with 50 mM adaSGC for 48hr re-
sulted in a significant increase in endogenous SGC. In addition,
a species corresponding to sulfolactosyl ceramide, immunore-
active with anti-SGC, was now detected (Figure 6). In contrast,Ltd All rights reserved
Chemistry & Biology
AdamantylSGC Augments DF508CFTR RescueFigure 5. Effect of Inhibitors of GSL
Synthesis on wtCFTR and DF508CFTR
Expression
Cells were treated with 2 mM P4 for 10 days, or
20 mM fumonisin B1 for 48 hr, or 30 mM sodium
chlorate for 48 hr. Western blots were performed
to analyze any changes in immature form (band b)
and fully glycosylated mature form (band c) of
wtCFTR and DF508CFTR. DF508R (rescued)
represents that DF508CFTR cells were incubated
under 26C–27C with 10% glycerol for 24 hr to
rescue the protein and recovered for 3 hr at
37C. Densitometric results using Image J are
plotted to show relative levels of bands b and c.
(A) P4 is a glucosyl ceramide synthase inhibitor
that prevents the synthesis of most GSLs except
those based on galactosyl ceramide such as
SGC. P4 inhibition of GSL synthesis has no effect
on DF508CFTR expression.
(B) Sodium chlorate is a sulfation inhibitor and
inhibits SGC synthesis. Incubation with 30mM
sodium chlorate for 48hrs reduces DF508CFTR
expression.
(C) Fumonisin B1 is an inhibitor of ceramide
synthase and prevents the synthesis of all GSLs.
Fumonisin B1 slightly increases DF508CFTR
expression but reduced rescue efficacy.SGCwas undetectable after cell treatment with sodium chlorate.
Thus, adaSGC can enter cells to modify endogenous sulfoglyco-
lipid metabolism. Detection of sulfolactosyl ceramide after treat-
ment implies adaSGC inhibition of desulfation as amechanism of
SGC accumulation.
Figure 6. Effect of AdaSGC on SGC Metabolism
WtCFTR-transfected BHK cells were cultured for 48 hr in the presence of
50 mM adaSGC or 30 mM sodium chlorate and the SGC content of the lipid
extract determined by anti-SGC-TLC immunostaining. Lane 1, SGC standard;
lane 2, untreated cells; lane 3, adaSGC-treated cells; lane 4, sodium-chlorate-
treated cells. AdaSGC treatment increased SGC and a new, more slowly
migrating species corresponding to sulfolactosyl ceramide was immunode-
tected. SGC was undetectable in sodium-chlorate-treated cells.Chemistry & Biology 16,Effect of CFTR on GSL Expression in Mouse Tissues
Our studies on CFTR-transfected cells indicated that functional
CFTR can stimulate SGC synthesis. A reduced SGC content
could therefore be a consequence of, and contribute to, the
phenotype in CF cells. To begin to study the effect of CFTR on
GSL synthesis in general and on SGC in particular, we compared
the SGC content of several tissues of DF508CFTR transgenic
and CFTR wild-type mice. Figure 7 shows that lung tissues in
DF508CFTR-transgenic mice express very low levels of SGC
as assessed by TLC immunostaining compared with wild-type
mice (Figure 7A). SGC is also a significant component of mouse
gastrointestinal epithelial cells and kidney cells. Similar to lung, in
the DF508CFTR mice, reduced level of SGC in the ileum and
kidney is seen by immunocytochemistry (Figure 7B). In the ileal
sections, SGC is expressed in the villus crypts from normal
mice. SGC is a major GSL in the mouse kidney (Lingwood
et al., 1981), but DF508CFTR-transgenic mouse kidney showed
no SGC. These results showed that there are dramatic changes
of SGC expression in CFTR defective mice.
DISCUSSION
These studies were initiated from our work showing that the
Hsp70 chaperone family members specifically bind SGC (Ma-
melak et al., 2001a) and that the SGC binding site was within
the N-terminal ATPase domain (Mamelak and Lingwood,
2001). Our initial studies suggested that the endogenous,
steady-state ATPase activity of Hsc70 was inhibited by this
compound. Interestingly, the results presented in this report indi-
cate that adaSGC only inhibited the Hsp40-stimulated ATPase
activity of the chaperone, as assessed in single-turnover assays.
The simplest interpretation of these observations is that the KCAT
for ATP hydrolysis is unaffected by adaSGC (which is measured
in single-turnover studies) but that an alternative step (such as461–470, April 24, 2009 ª2009 Elsevier Ltd All rights reserved 465
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AdamantylSGC Augments DF508CFTR RescueFigure 7. SGCContent ofWild-Type andDF508CFTRMouse Tissues
(A) TLC immunostaining. Total lipids were extracted from lung. Anti-SGC was
used to detect SGC levels. Bovine SGC was used as a standard. Total lipid
was assessed by iodine staining.
(B) Tissue immunohistochemistry. Frozen kidney and ileum sections fromwild-
type (WT) and DF508CFTR mice were stained with anti-SGC. SGC is found in
WT ileal crypts and villus tips (arrows) butDF508CFTR ileum showed little SGC
expression. In WT kidney, most tubules but no glomeruli expressed SGC. No
SGCwas detected in DF508CFTR kidney. Two or three animals were tested in
each group.nucleotide binding or release) is impacted by the lipid. Moreover,
unlike other inhibitors of Hsc70 ATPase activity (Fewell et al.,
2001), adaSGC prevents peptide binding, which occurs in the
C-terminal domain of Hsp70s.We therefore believe that adaSGC
association with the N-terminal domain directly hinders Hsp40
binding (which also occurs in the ATPase domain). In addition,
adaSGC most likely impacts a conformational cascade that is
required to ‘‘open’’ the peptide-binding site, an event that is
known to require ATP binding.
The Hsc70 cognate examined in these studies is a member of
the Hsp70 family and is involved in the ERAD of misfolded
proteins such as DF508CFTR (Meacham et al., 2001; Arndt
et al., 2005). Prevention of DF508CFTR ERAD degradation is
a major focus of CF research because a relatively minor increase
in DF508CFTRmaturation and cell surface expression is consid-
ered of potential therapeutic benefit (Farmen et al., 2005).
Indeed, several studies examining inhibition of Hsc70 have
been carried out. These have been met with variable success.
Deoxyspergualin (DSG) is an Hsc70 inhibitor (Nadler et al.,
1992), effective to partially correct DF508CFTR in vitro (Jiang
et al., 1998), but Farinha et al. (2002) reported that DSG only
slightly stabilizes the immature form of wtCFTR. Although used466 Chemistry & Biology 16, 461–470, April 24, 2009 ª2009 Elsevierwidely as an immunosuppressant, clinical studies in CF have
yet to be reported. Sodium phenyl butyrate (4-PBA) reduces
Hsc70 expression in cell culture to promoteDF508CFTRmatura-
tion (Rubenstein et al., 1997; Rubenstein and Lyons, 2001), but
the effect on chloride transport has been questioned (Loffing
et al., 1999) and the increased instability of DF508 by 4-PBA
was also reported (Farinha et al., 2002). 4-PBA treatments
have yielded initial encouraging results in vivo (Rubenstein and
Zeitlin, 1998; Zeitlin et al., 2002), but the selectivity of action is
broad (Singh et al., 2006; Wright et al., 2004) and early clinical
studies have not been followed up. Finally, improved short chain
fatty acid analogs have been reported to be effective in vitro
(Nguyen et al., 2006), but have yet to be tested in vivo. We
were unable to demonstrate any change in DF508CFTR pro-
cessing in transfected BHK cells in vitro using these butyric
acid derivatives (data not shown).
Accumulating evidence indicates that wtCFTR and
DF508CFTR are subjected to differential ERAD regulation
(Farinha and Amaral, 2005; Brodsky, 2007). SGC depletion
affects only DF508CFTR, not wtCFTR, supporting wtCFTR and
DF508CFTR participation in different ERAD pathways. AdaSGC
protection against DF508CFTR ERAD is consistent with, but
does not prove, cellular Hsc70 inhibition.
Our studies infer that in both the BHK transfectants and CFTR-
defective transgenic mice, CFTR plays a tissue selective role in
regulating the biosynthesis of SGC (and other GLS). Hyperacidi-
fication of the Golgi and trans-Golgi network has been ascribed
as the basis for altered glycosylation in CF (Poschet et al., 2002).
Extrapolating from our studies indicating that the SGC mimic,
adaSGC can attenuate Hsc70-mediated ERAD, endogenous
SGC could be a component of the physiological mechanism
by which cells can regulate Hsp70 family chaperone activity. In
the case of CF associated with the DF508CFTR protein, this
could be of double importance: the reduced SGC levels in CF
tissue might compound the efficacy of DF508CFTR removal by
ERAD. AdaSGC ismembrane soluble and could be endocytosed
and trafficked to the Golgi as other similar derivatized GSLs
(Pagano, 2003). However, amphipathic adaSGC might also
access cytosolic Hsc70, whereas SGC would be expected to
interact only with Hsp70 family members within the ER. The
adaSGC-increased endogenous SGC cell content might play
a role in the DF508CFTR protection, but it remains to be shown
whether CFTR-dependent changes in endogenous SGC levels
are more than coincidental. The bulk of intracellular SGC is,
appropriately, consistent with an ER location. CFTR can function
as a nucleotide channel for membrane transport of adenosine
30phosphate 50-phosphosulfate (PAPS) (Pasyk and Foskett,
1997). Because PAPS is the universal sulfate donor used for
SGC synthesis (Sakac et al., 1992), this provides a potential
basis of the CFTR-regulated SGC synthesis we report.
Recent work highlighted the phenotypic similarity between CF
and Niemann-Pick disease type C (White et al., 2004, 2007;
Gentzsch et al., 2007), in that both show a defect in cholesterol
metabolism. In many GSL-associated lysosomal storage
diseases, a link between GSL and cholesterol trafficking has
been established (Pagano, 2003). Defects in GSL metabolism
result in altered intracellular trafficking of both GSL and choles-
terol (Pagano et al., 2000). Similarly, defects in cholesterol
metabolism, as in Niemann-Pick type C, result in aberrant GSLLtd All rights reserved
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GSL trafficking, and vice versa (Choudhury et al., 2002). Indeed,
it has been proposed that the primary defect in Niemann-Pick
type C is not in cholesterol but in GSL metabolism, and that
cholesterol accumulation is a secondary effect (Gondre-Lewis
et al., 2003). Thus, cholesterol and GSL homeostasis are func-
tionally linked. If defects in CFTR affect cholesterol trafficking,
we might expect changes in GSL in CF. Initial studies indicate
that loss of CFTR has significant tissue-restricted effects on
the GSL profile. Whether these turn out to be related to choles-
terol (lipid raft) trafficking, as in Niemann-Pick type C, will be of
interest. Thorough GSL analysis of the tissues of CFTR knockout
and DF508CFTR mice is required. Our studies in progress indi-
cate that not only are selective GSLsmissing, but also alternative
GSLs are made (data not shown). Recent work showed age-
dependent ceramide accumulation in CFTR-deficient mice,
implicating changes in glycosphingolipid homeostasis (Teich-
graber et al., 2008). In our study, fumonisin B1, a ceramide syn-
thase inhibitor, slightly increased the amount of fully mature
CFTR in DF508CFTR cells. Fumonisin B1 treatment decreases
not only SGC but also ceramide levels, which might favor the
expression of the mature glycosylated form of DF508CFTR.
Nevertheless, both fumonisin and sodium chlorate depletion of
SGC inhibited low-temperature glycerol rescue of DF508CFTR,
whereas depletion of other GSLs was without effect, implying
a protective role for endogenous SGC.
The present studies have assessed SGC synthesis in relation to
CFTR. The reduced renal SGC content of CFTR-deficient mice
correlates with renal CFTR (and a renal-specific variant) expres-
sion. CFTR is in proximal and distal tubules but not glomeruli
(Devuyst et al., 1996), which corresponds to the expression
pattern of SGC (Trick et al., 1999). In addition, significant tissue-
selective changes in other GSLs are also found in CFTR-defective
mice (studies in progress) such that differential GSL biosynthesis
might be a previously unrecognized phenotype of CF. Defects in
CFTR have been associated with altered GSL content in terms
of GM1 and gangliotetraosyl ceramide (Gg4) content. Defective
CFTR-mediated change in Golgi pH was reported to block sialy-
lation and hence decrease GM1 and increase asialoGM1 (Gg4)
(Poschet et al., 2001). However, this is more complex, because
Gg4 is not the precursor to GM1. CFTRmight play additional roles
in the regulation of GSL biosynthesis.
The efficacy of adaSGC to increase DF508CFTR degradation
escape but only promote maturation/iodine efflux during low-
temperature glycerol rescue suggests that ERAD escape alone
is insufficient to promote DF508CFTR cell surface trafficking.
Unknown additional signals within the ER must be necessary
for the further anterograde trafficking of DF508CFTR.
Our study shows wtCFTR is associated with increased SGC
synthesis, which might restrict Hsc70 chaperone activity. SGC
depletion in DF508CFTR-expressing cells might increase
DF508CFTR ERAD. Because adamantylSGC, a soluble SGC
analog, can induce DF508CFTR ERAD escape, SGC or SGC
analogs might augment therapeutic approaches for CF.
SIGNIFICANCE
These studies indicate that adamantylSGC inhibition of
Hsc70 ATPase and peptide binding can reduce cellularChemistry & Biology 16Hsc70 chaperone function within ERAD, allowing partial
DF508CFTR escape and increasing the potential for thera-
peutic rescue of this misfolded protein. Lower SGC levels
in DF508CFTR cells might contribute to rapid DF508CFTR
ER degradation.
EXPERIMENTAL PROCEDURES
Cell Culture
BHK cells (either mock or HA-tagged wtCFTR or DF508CFTR transfected)
were a generous gift from Dr. G. Lukacs (McGill University, Montreal, Canada).
Cells were maintained in DMEM/Ham’s F12 (Wisent) in 5% FBS, 1% antibi-
otics (10,000 mg streptomycin ml1 and 10,000 IU penicillin; Wisent) and
250 mg methotrexate ml1 (Sharma et al., 2001, 2004). The cystic fibrosis
cell line IB3-1 (DF508/W1282X) and the S9 (IB3 cells transfected with wtCFTR)
were maintained in LHC-8 serum free medium supplemented with 5% FBS
and 1% antibiotics as described previously (Emam et al., 2006). Adaman-
tylSGC was synthesized from SGC as previously described (Whetstone and
Lingwood, 2003).
Single-Turnover Hsc70 ATPase Assay
Single-turnover ATPase assays employing a constitutively expressed form of
the yeast Hsp70 chaperone, Ssa1p (Hsc70), and a 2-fold molar excess of
a J domain-containing cochaperone, T antigen, were performed as described
elsewhere (Fewell et al., 2004) in the absence or presence of increasing
concentrations of adaSGC or 300 mM adaSGC.
Hsc70-Peptide Binding Assay
125I-labeled carboxymethylated a-lactalbumin (CMLA) was prepared and
binding to the yeast Hsp70 chaperone, Ssa1p, was performed as previously
described (McClellan et al., 1998; McClellan and Brodsky, 2000). Where indi-
cated, adaSGC (100 mM final concentration) or an equivalent volume of water
was preincubated during peptide-Ssa1p complex formation at 4C in the pres-
ence or absence of an equimolar concentration of a J domain-containing
Hsp40 from yeast, Ydj1p. CMLA/Hsc70 complexes were detected using non-
denaturing gel electrophoresis by band shift assay.
AdamantylSGC Treatment and Modulation of GSL Synthesis
Cells were treated with 25 mM or 50 mM adaSGC, unless otherwise stated, for
48 hr. To ‘‘rescue’’DF508CFTR, one set ofDF508CFTR cells were incubated at
26C –27C/10% glycerol (Denning et al., 1992; Brown et al., 1996) for another
24 hr after 1 day incubation with adaSGC. Cells were then washed thoroughly
and recovered for 3 hr at 37C. For inhibition of GSL biosynthesis, cells were
treated with 20 mM fumonisin B1 (Sigma) or 30 mM sodium chlorate (Sigma)
for 48 hr or 2 mM P4 (1-phenyl-2-palmitoylamino-3-pyrrolidino-1-propanol,
a gift from Dr. Shayman (University of Michigan) for 10 days (Lee et al.,
1999). After the treatment, either total lipid or cell lysates were prepared for
further analysis.
GSL Extraction
GSLs were extracted from exponentially growing cells. The cells were pelleted
by centrifugation at 1000 3 g for 5 min. The GSLs were extracted by Folch
partition (chloroform: methanol: water, 2:1:0.6, v/v/v). For tissue extraction,
tissues were homogenized in phosphate-buffered saline (PBS) and extracted
overnight with 20 volumes of chloroform: methanol (2:1, v/v). The suspension
was filtered by glasswool column and partitioned by the Folch method. The
lower phase was collected and dried down under a mild N2 gas stream.
Samples were saponified with 1 N NaOH in methanol for 2 hr at 37C or over-
night at room temperature (RT). Five milliliters of water was added, and the
mixture applied onto a C-18 column (Sep-Pak Plus C-18; Waters). The column
was washed with water, and glycolipids were eluted with methanol, dried and
resuspended in chloroform:methanol (2:1, v/v).
TLC Immunostaining
Equivalent GSL aliquots, based on cell number, were separated by TLC and
plates were dried and blocked with 1% bovine serum albumin (BSA) in TBS
(50 mM Tris, 154 mM NaCl [pH 7.4]) at RT for 1 hr. Plates were incubated, 461–470, April 24, 2009 ª2009 Elsevier Ltd All rights reserved 467
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(Go¨teborg University, Sweden) (Fredman et al., 1988). After three washes
with TBS, plates were incubated with peroxidase-conjugated goat anti-mouse
antibody. Antibody binding was visualized with enhanced chemiluminescent
system (ECL, Pierce) or 4-chloro-1-naphthol (Sigma; 3 mg/ml methanol) and
hydrogen peroxide (Nutikka et al., 2003).
Western Blot and Immunoprecipitation
Cells were grown on six-well plates and treated with 25 mM or 50 mM adaSGC,
unless otherwise stated, for 48 hr. To rescue DF508CFTR, one set of
DF508CFTR cells was incubated at 26C–27C/10% glycerol (Denning et al.,
1992; Brown et al., 1996) for another 24 hr after 1 day incubation with adaSGC.
Cells were then washed thoroughly and recovered for 3 hr at 37C. For inhibi-
tion of GSL biosynthesis, cells were treatedwith 20 mM fumonisin B1 (Sigma) or
30 mM sodium chlorate (Sigma) for 48 hr or 2 mM P4 (1-phenyl-2-palmitoyla-
mino-3-pyrrolidino-1-propanol, a gift from Dr. Shayman) for 10 days (Lee
et al., 1999). Cells were lysed with TNTE lysis buffer (10 mM Tris [pH 7.4],
154 mM NaCl, 1mM EDTA, 1% Triton X-100, protease inhibitor cocktail;
Sigma) and incubated for 30 min at 4C in a shaker. Samples were centrifuged
at 12,000 3 g for 20 min at 4C and the supernatant was collected. Protein
concentration was quantified with BCA method (Pierce). Equal amounts
(50 mg) of total protein were analyzed by 6% SDS-PAGE, unless otherwise
stated. CFTR expression was detected using anti-HA (Covance) or anti-CFTR
(Chemicon). For immunoprecipitation, 500 mg total lysate was incubated with
anti-HAovernight. Immune complexeswere capturedwith precleared recombi-
nant ProteinA agarose (Exalpha). Beads were washed three times with lysis
buffer without Triton X-100 and resuspended with 2X sample buffer. Proteins
were detected with anti-CFTR. Control samples were incubated with isotype
immunoglobin G (IgG) instead of anti-HA.
Immunofluorescence Microscopy
BHK cells were grown on glass coverslips for 24 hr. Cells were fixed with 4.0%
paraformaldehyde for 15min at 4C and permeabilized with 0.2% Triton X-100
for 2 min at 20C. Cells were blocked with PBS-10% FBS overnight at 4C,
incubated with 1:400 dilution of anti-SGC antibody. After three washes with
PBS, the cells were incubated with TRICTC-labeled goat anti-mouse antibody
for 1 hr. Fluorescent images were taken using a Zeiss LSM510 confocal micro-
scope under a 633 oil-immersion objective.
Iodide Efflux Assay
Iodide efflux assay was performed as previously described (Mohamed et al.,
1997). Briefly, cells grown in six-well culture dishes were incubated with
loading buffer (136 mM NaI, 3mM KNO3, 2 mM Ca[NO3]2, 11 mM glucose,
and 20 M HEPES [pH 7.4]) for 1 hr at RT. After washing away extracellular
NaI thoroughly with efflux buffer containing 136 mM NaNO3, 1 ml efflux buffer
was loaded three times for 1 min to establish a baseline. Efflux buffer contain-
ing agonists (10 mM forskolin [Sigma], 0.2 mMCTP-cAMP [Sigma], and 0.2mM
isobutylmethylxanthine [Sigma]) were added (time zero) for 1min and
collected. Three or four additional 1 ml efflux buffer aliquots containing
agonists were incubated for 1 min and collected. The standard curve was
generated with a known NaI solution each time and the amount of iodide in
each sample was measured with an iodide-selective electrode (Orion).
DF508CFTR Mice
All mouse studies were approved by the animal care committee at Hospital for
Sick Children, Toronto. Wild-type mice (C57Bl/6J, Cftr+/+) and matched litter-
mate DF508 (Cftrtm1kth) mice were maintained on a liquid diet (Peptamen,
Nestle Nutrition). At age 10 weeks, lung, ileum, and kidney were harvested.
Tissues were either frozen and stored at 80C until lipid extraction or
embedded in OTC (Tissue Tek), frozen in liquid nitrogen, and stored at
80C. Tissues were cryosectioned (5 mM) and stored at 80C.
Immunohistochemistry
Serial 5 mM cryosections were thawed and dried overnight at RT. Procedures
was performed with M.O.M. Peroxidase Kit according to manufacturer’s
protocol except for a few modifications (Vector Laboratories). Throughout all
incubation steps, slides were kept in a humidified chamber at RT. Briefly tissue
sections were blocked with endogenous peroxidase blocker (Universal Block,468 Chemistry & Biology 16, 461–470, April 24, 2009 ª2009 ElsevierKPL) for 30 min. After washing with PBS, tissues were incubated with Avidin
solution for 15 min, followed by 15 min with biotin solution (avidin/biotin block-
ing kit, Vector Laboratories). Tissue sections were further blocked with
M.O.M. IgG blocking solution. Slideswere incubatedwith anti-SGC antibody
(1:200) diluted with M.O.M. diluent for 30 min. After a wash with PBS, the
slides were incubated with M.O.M. biotinylated anti-mouse IgG working
solution for 10 min. Following the wash step, Vectastain ABC reagents were
applied for 5min. Sections were developed using DAB (3,30-diaminobenzidine)
substrates for 1–2 min. To stop the DAB reaction, sections were dipped in
distilled water for 5 min. Hematoxylin counterstain was applied for 30 s and
excess staining was removed by immersion in tap water for 10 min. Sections
were dehydrated twice for 3 min in, sequentially, 70%, 95%, and 100%
ethanol, cleared in xylene for 5 min, and mounted in Permount (Fisher Scien-
tific). Images were taken using an Olympus BX60 microscope.
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